Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy

Summary

OBJECTIVES: I. Determine whether albuterol increases strength in patients with facioscapulohumeral dystrophy as measured by quantitative voluntary isometric contraction testing. II. Determine whether albuterol increases muscle mass in this patient population as determined by 24 hour urinary creatinine excretion and dual energy x-ray absorptiometry (DEXA). III. Examine the long term safety of albuterol in this patient population.

Timeline

Start

1998-01

Primary completion

—

Completion

2000-09

Drugs

Indications